These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 26931135)

  • 1. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.
    Cleasby ME; Jamieson PM; Atherton PJ
    J Endocrinol; 2016 May; 229(2):R67-81. PubMed ID: 26931135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.
    Consitt LA; Clark BC
    J Frailty Aging; 2018; 7(1):21-27. PubMed ID: 29412438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age--An overview.
    Buch A; Carmeli E; Boker LK; Marcus Y; Shefer G; Kis O; Berner Y; Stern N
    Exp Gerontol; 2016 Apr; 76():25-32. PubMed ID: 26785313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study.
    Kim TN; Park MS; Lim KI; Choi HY; Yang SJ; Yoo HJ; Kang HJ; Song W; Choi H; Baik SH; Choi DS; Choi KM
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):525-32. PubMed ID: 22563924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III.
    Srikanthan P; Hevener AL; Karlamangla AS
    PLoS One; 2010 May; 5(5):e10805. PubMed ID: 22421977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationships between sarcopenic skeletal muscle loss during ageing and macronutrient metabolism, obesity and onset of diabetes.
    Welch AA; Hayhoe RPG; Cameron D
    Proc Nutr Soc; 2020 Feb; 79(1):158-169. PubMed ID: 31685055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning.
    Levine ME; Crimmins EM
    Obesity (Silver Spring); 2012 Oct; 20(10):2101-6. PubMed ID: 22310233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
    Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
    Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity.
    Rivas DA; McDonald DJ; Rice NP; Haran PH; Dolnikowski GG; Fielding RA
    Am J Physiol Regul Integr Comp Physiol; 2016 Apr; 310(7):R561-9. PubMed ID: 26764052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments.
    Wang M; Tan Y; Shi Y; Wang X; Liao Z; Wei P
    Front Endocrinol (Lausanne); 2020; 11():568. PubMed ID: 32982969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia.
    Tournadre A; Vial G; Capel F; Soubrier M; Boirie Y
    Joint Bone Spine; 2019 May; 86(3):309-314. PubMed ID: 30098424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences.
    Hong SH; Choi KM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenic obesity.
    Polyzos SA; Margioris AN
    Hormones (Athens); 2018 Sep; 17(3):321-331. PubMed ID: 30014320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.
    Kalinkovich A; Livshits G
    Ageing Res Rev; 2017 May; 35():200-221. PubMed ID: 27702700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia is associated with albuminuria independently of hypertension and diabetes: KNHANES 2008-2011.
    Han E; Lee YH; Kim G; Kim SR; Lee BW; Kang ES; Ahn CW; Cha BS
    Metabolism; 2016 Oct; 65(10):1531-40. PubMed ID: 27621188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Syndrome and Sarcopenia.
    Nishikawa H; Asai A; Fukunishi S; Nishiguchi S; Higuchi K
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The most effective factors to offset sarcopenia and obesity in the older Korean: Physical activity, vitamin D, and protein intake.
    Oh C; Jeon BH; Reid Storm SN; Jho S; No JK
    Nutrition; 2017 Jan; 33():169-173. PubMed ID: 27717662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance.
    Meng P; Hu YX; Fan L; Zhang Y; Zhang MX; Sun J; Liu Y; Li M; Yang Y; Wang LH; Zhang Y; Gao W; Han XQ; Chen LK
    Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():29-35. PubMed ID: 24450558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons--a narrative review.
    Goisser S; Kemmler W; Porzel S; Volkert D; Sieber CC; Bollheimer LC; Freiberger E
    Clin Interv Aging; 2015; 10():1267-82. PubMed ID: 26346071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.